![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gediya Lalji K Njar Vincent CO
Publisher: Informa Healthcare
ISSN: 1746-0441
Source: Expert Opinion on Drug Discovery, Vol.4, Iss.11, 2009-11, pp. : 1099-1111
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Advances in the development of hybrid anticancer drugs
Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anticancer Drugs Discovery and Development from Marine Organisms
Current Topics in Medicinal Chemistry, Vol. 9, Iss. 16, 2009-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Challenges of biomarkers in drug discovery and development
Expert Opinion on Drug Discovery, Vol. 7, Iss. 6, 2012-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-Cancer Drug Discovery and Development Summit
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. :